Bio-Techne
$72.40Change from previous close: 0.00%
At a glance
- Revenue growth
- −0.38%
- FY to Jun 2026 vs FY to Jun 2025
- Net income growth
- +147.77%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- 15.0%
- FY to Jun 2025: 6.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total assets | 2,587 | 2,551 | 2,523 | 2,526 | 2,558 | — |
| Current assets | 744 | 688 | 637 | 610 | 608 | — |
| Cash and equivalents | 265 | 210 | 173 | 145 | 162 | — |
| Short-term investments | — | — | — | — | 0.0 | 0.0 |
| Receivables | 217 | 215 | 185 | 184 | 207 | — |
| Inventory | 196 | 201 | 205 | 203 | 189 | — |
| Net property, plant and equipment | 299 | 301 | 303 | 311 | 319 | — |
| Goodwill | 975 | 978 | 981 | 979 | 981 | — |
| Other intangible assets | 303 | 319 | 335 | 350 | 366 | — |
| Long-term investments | 246 | 246 | 250 | 259 | 251 | — |
| Current liabilities | 164 | 153 | 140 | 145 | 176 | — |
| Accounts payable | 26.7 | 23.5 | 26.3 | 30.2 | 25.3 | — |
| Long-term debt | 200 | 200 | 260 | 300 | 346 | — |
| Total debt | 289 | 290 | 351 | 394 | 444 | — |
| Total liabilities | 479 | 465 | 512 | 560 | 639 | — |
| Total equity (incl. minority) | 2,108 | 2,085 | 2,011 | 1,966 | 1,919 | — |
| Retained earnings | 1,144 | 1,145 | 1,107 | 1,083 | 1,066 | — |
| Minority interest | — | — | — | — | 0.0 | — |